C
CNSP
CNS Pharmaceuticals
5.44
+0.55+11.25%After Hours: 5.04 -0.40 -7.40%19:18 05/29 EDT
OPEN/PREV CLOSE5.17/5.28
TODAY RANGE4.960-5.17
VOL13.67K
MARKET CAP7.31M
52 WEEK RANGE1.900-12.96
AVG VOL (3M)1.42M
% TURNOVER0.94%
TURNOVER--
P/E (TTM)-0.1714
% RANGE3.60%
EPS(TTM)-29.1797
P/E(FORWARD)-3.0303
P/B57.41
BVPS0.0871
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP7.27M
SHARES OUTSTANDING1.46M
NEXT EARNINGS08/12-08/17
FREE FLOAT1.45M
LOT SIZE1
EX-DATE07/22/2025
News
Press Releases
Financial Reports
Profile
Benzinga·05/26 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·05/21 02:09
Insider Boost: CNS Pharmaceuticals Director Quietly Ramps Up His Stake
TipRanks·05/19 21:01
CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders
TipRanks·05/15 13:26
Maxim Group Sticks to Their Buy Rating for CNS Pharmaceuticals (CNSP)
TipRanks·05/14 16:25
CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year
TipRanks·05/14 16:22
CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months
Benzinga·05/14 12:28
CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate
Seeking Alpha·05/14 12:06
CNS Pharmaceuticals reports Q1 results
Benzinga·05/11 17:05
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga·05/06 13:51
What's Going On With CNS Pharmaceuticals Stock On Wednesday?
TipRanks·05/05 16:22
3 Penny Stocks to Watch Now, 5/5/26
Benzinga·05/05 12:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Reuters·05/04 18:05
BUZZ-U.S. STOCKS ON THE MOVE-Mirum Pharma
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.